Airway diseases
Interstitial lung diseases
E-poster
Moving forward in various aspects of sarcoidosis
Aims : This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Methods :
General respiratory patient care, Pulmonary function testing, Imaging, Epidemiology, Physiology, Cell and molecular biology, Public health, Endoscopy and interventional pulmonology
Human dendritic cells with PD-1+ CD80+ expression from lymph nodes aspirates of sarcoidosis patients.
E. Rutkowska(Warsaw, Poland)
COI
1
Is there a link between autophagy, sarcoidosis, and non granulomatous neurological disorders?
T. El Jammal(Strasbourg, France)
COI
2
Mitophagy, at the crossroads of genetic pathways involved in sarcoidosis and host-pathogen interactions with SARS-COV2 proteins
A. Calender(Lyon, France)
COI
3
Cryptococcosis in a sarcoidosis patient with impaired response to IL-2
T. El Jammal(Strasbourg, France)
COI
4
The role of nonspecific inflammation factors – SA-A and pentraxin-3 in patients with respiratory sarcoidosis in different age groups
N. Demyanenko(Moskow, Russian Federation)
COI
5
HLA Associations in Czech Patients with Sarcoidosis
M. Petřek(Olomouc, Czech Republic)
COI
6
Influence of HLA class II DRB1*/DQB1* alleles in phenotypes of Indian patients of sarcoidois.
d. rosha(Noida, India)
COI
7
Comorbidity of sarcoidosis in mountainous regions of Western Ukraine: a based-cohort (n=592) patients analysis
K. Shvets(Ivano-Frankivsk, Ukraine)
COI
8
Seasonality of hypercalcemia - A population-based study on patients with pulmonary sarcoidosis
J. Rødsgaard(Odense C, Denmark)
COI
9
The role of calcium metabolism assessment in the clinical setting of interstitial lung diseases
P. Cameli(Siena (SI), Italy)
COI
10
The features of sarcoidosis in owerweight patients.
E. Shchepikhin(Moscow, Russian Federation)
COI
11
Cardio-pulmonary exercise test and 1-minute sit-to-stand test correlation in patients with sarcoidosis.
I. Kokkonouzis(Peristeri - Athens, Greece)
COI
12
Löfgren syndrome in patients with sarcoidosis: 25 years` observational study in Kharkiv, Ukraine
O. Konstantynovska(Kharkiv, Ukraine)
COI
13
Comparative review of older-onset and younger-onset sarcoidosis in endobronchial biopsy-confirmed cases
M. Brennan(Galway, Ireland)
COI
14
An Audit on the Screening of Biopsy Confirmed Sarcoidosis in a University Hospital
N. Boyle(Celbridge, Ireland)
COI
15
Prevalence of small fiber neuropathy in patients with sarcoidosis in an outpatient setting.
N. Bernardinello(Trecenta (RO), Italy)
COI
16
Quality of Life in Patients with Sarcoidosis Combined with Irritable Bowel Syndrome
A. Zeinalova(Donetsk, Ukraine)
COI
17
Fatigue, coping, anxiety and depression in patients with sarcoidosis
L. Charvoz(Lausanne, Switzerland)
COI
18
Short term treatment response in pulmonary sarcoidosis – a prospective study
A. Thomas(Pathanamthitta, India)
COI
19
The course of COVID-19 in pulmonary sarcoidosis patients, receiving methotrexate
I. Merenkova(Kyiv, Ukraine)
COI
20
. . .
